Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 1Phase 1 1

Status

Completed 8Terminated 6Unknown 5Active not recruiting 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2OTHER_GOV 1

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 2Other solid neoplasm 1Gynecologic 1Gastrointestinal 1

Conditions

Breast Neoplasms 2Breast Diseases 2Solid Tumors 1Serous Ovarian Cancer 1Gastric Adenocarcinoma 1

Interventions

Cisplatin 504Cyclophosphamide 353Radiotherapy 349Carboplatin 347Capecitabine 328Oxaliplatin 319Paclitaxel 316Gemcitabine 315Docetaxel 308Fluorouracil 281apatinib 240Drug Therapy 239Bevacizumab 224camrelizumab 212Etoposide 199Irinotecan 176Doxorubicin 174Dexamethasone 159Leucovorin 158sintilimab 140Pemetrexed 136Cytarabine 136pembrolizumab 135anlotinib 135toripalimab 124S 1 (combination) 119Neoadjuvant Therapy 119Vincristine 118Rituximab 114Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Unknown × Interventional × Drug Evaluation × Clear all
NCT06055348 2023-09-26

SC0191 Plus Chemotherapy in Advanced Ovarian Canceradvanced Ovarian Cancer

Biocity Biopharmaceutics Co., Ltd.

Phase 1/2 Unknown
112 enrolled
Gynecologic

Serous Ovarian Cancer

NCT04972422 2021-09-05

A Phase 1b Study of ZN-c3 in Chinese Subjects

Zentera Therapeutics HK Limited

Phase 1 Unknown
38 enrolled
Other solid neoplasm

Solid Tumors

NCT04121039 2019-10-09

Study of the Apatinib Combine With POF Versus POF in Gastric Cancer

Fujian Cancer Hospital

Phase 2 Unknown
116 enrolled
Gastrointestinal

Gastric Adenocarcinoma

NCT04088110 2019-09-12

Pyrotinib Combined With Trastuzumab Plus Aromatase Inhibitor in Treatment of Breast Cancer

Fuzhou General Hospital

Phase 2 Unknown
77 enrolled
Breast

Breast Diseases, Breast Neoplasms

NCT03910712 2019-04-10

Pyrotinib

Peking Union Medical College Hospital

Phase 2 Unknown
250 enrolled
Breast

Breast Diseases, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡